Nebivolol induces distinct changes in profibrosis MicroRNA expression compared with atenolol, in salt-sensitive hypertensive rats

Hongmei Ye, Shukuan Ling, Alexander C. Castillo, Bejoy Thomas, Bo Long, Jinqiao Qian, Jose R. Perez-Polo, Yumei Ye, Xiaoping Chen, Yochai Birnbaum

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Nebivolol is a selective β1-blocker with nitric oxide-enhancing effects. MicroRNAs are small noncoding RNA molecules that downregulate gene expression. We compared the effects of nebivolol and atenolol, a first generation β1-selective blocker, on left ventricular hypertrophy, fibrosis, and function and microRNA expression in a rodent model of hypertension. Dahl salt-sensitive rats received either low-salt chow (control) or AIN-76A high-salt (8% NaCl) diet and randomized to vehicle (high-salt), nebivolol (20 mg/kg per day), or atenolol (50 mg/kg per day) for 8 weeks. High-salt induced left ventricular hypertrophy and fibrosis and decreased the expression of miR-27a,-29a, and-133a. Nebovolol attenuated deterioration of left ventricular systolic function, remodeling, and fibrosis more than atenolol, despite similar effects on heart rate and blood pressure. Nebivolol, but not atenolol, prevented the decrease in miR-27a and-29a induced by high-salt. Nebivolol and atenolol equally attenuated the decrease in miR-133a. In vitro overexpression of miR-27a,-29a, and-133a inhibited cardiomyocyte hypertrophy and reduced collagen expression. Both miR-27a and-29a target Sp1, and miR-133a targets Cdc42. Pharmacological inhibition of Sp1 and Cdc42 decreased myocardial fibrosis and hypertrophy. Our data support a differential microRNAs expression profile in salt-induced hypertension. Nebivolol substantially attenuated cardiac remodeling, hypertrophy, and fibrosis more than atenolol. These effects are related to attenuation of the hypertension-induced decrease in miR-27a and-29a (with a subsequent decrease in Sp1 expression) and miR-133a (with a subsequent decrease in Cdc42).

Original languageEnglish (US)
Pages (from-to)1008-1013
Number of pages6
JournalHypertension
Volume61
Issue number5
DOIs
StatePublished - May 2013

Keywords

  • fibrosis
  • hypertension
  • microRNA
  • remodeling
  • β-blocker

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Nebivolol induces distinct changes in profibrosis MicroRNA expression compared with atenolol, in salt-sensitive hypertensive rats'. Together they form a unique fingerprint.

  • Cite this

    Ye, H., Ling, S., Castillo, A. C., Thomas, B., Long, B., Qian, J., Perez-Polo, J. R., Ye, Y., Chen, X., & Birnbaum, Y. (2013). Nebivolol induces distinct changes in profibrosis MicroRNA expression compared with atenolol, in salt-sensitive hypertensive rats. Hypertension, 61(5), 1008-1013. https://doi.org/10.1161/HYPERTENSIONAHA.111.00892